Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Folia Histochem Cytobiol ; 48(4): 589-96, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21478102

ABSTRACT

To test the probable osteoinductive properties of NanoBone, a new highly non-sintered porous nano-crystalline hydroxylapatite bone substitute embedded into a silica gel matrix, granules were implanted subcutaneously and intramuscularly into the back region of 18 mini pigs. After periods of 5 and 10 weeks as well as 4 and 8 months, implantation sites were investigated using histological and histomorphometric procedures. Signs of early osteogenesis could already be detected after 5 weeks. The later periods were characterized by increasing membranous osteogenesis in and around the granules leading to the formation of bone-like structures showing periosteal and tendon-like structures with bone marrow and focal chondrogenesis. Bone formation was better in the subcutaneous than in the intramuscular implantation sites. This ectopic osteogenesis is discussed with regard to the nanoporosity and microporosity of the material, physico-chemical interactions at its surface, the differentiation of osteoblasts, the role of angiogenesis and the probable involvement of growth factors. The results of this preliminary study indicate that this biomaterial has osteoinductive potential and induces the formation of bone structures, mainly in subcutaneous adipose tissue in the pig.


Subject(s)
Bone Substitutes/chemistry , Bone and Bones/anatomy & histology , Durapatite/chemistry , Osteogenesis , Silicon Dioxide/chemistry , Animals , Drug Combinations , Osteoblasts/cytology , Swine , Swine, Miniature
2.
J Maxillofac Oral Surg ; 9(1): 80-1, 2010 Mar.
Article in English | MEDLINE | ID: mdl-23139576

ABSTRACT

OBJECTIVES: The distinction between a pseudocyst and an intervention demanding cyst or process cannot always be found by 2D radiology. The differential diagnosis of a pseudocyst may become more difficult when adjacent processes are present. CASE: A symptom free 67-years-old man presented with a periapical radiolucency around the mandibular left second molar as well as at the impacted 3rd molar. A comparison with an older panoramic x-ray showed no expansion during a 27 months period. The new panoramic x-ray and addtional Digital Volume Tomography (DVT) showed asymptomatic separate dental cyst at the impacted wisdom tooth and the missing lingual cortical border in the apical region of the 2nd lower molar. This finding along with clinical vitality of the 1st and 2nd left molars led to the conclusion that the presented pathology was a Stafne Idiopathic Bone Cyst (SIBC) which needed no surgical intervention. DISCUSSION: The additional use of DVT 3D examination may help in diagnosis of SIBC prior to surgical interventions thus avoiding unwanted surgical intervention.

3.
J Orofac Orthop ; 68(4): 266-77, 2007 Jul.
Article in English, German | MEDLINE | ID: mdl-17639275

ABSTRACT

Previous studies on the development of cleft lip, alveolus, palate, and velum and neural tube defects have revealed several shared multifactorial causes. Both anomalies emerge at different times during embryonic development and are not associated with each other unless there is a genetic component to the etiology. Vitamin deficiency disorders are one of several factors contributing to the etiology of these anomalies.Vitamins B6, folic acid and B12 play an essential role in the methylation cycle. A lack of or deficiency in these vitamins thus has severe consequences for the organism, especially the unborn child. Due to its short half-life, vitamin B6 is particularly important for undisturbed embryogenesis and should be taken along with folic acid as a periconceptional supplement to prevent embryonic deformities. This paper is intended to provide the orthodontist (as a member of the interdisciplinary cleft team) with an overview of the issues and etiological significance of vitamin B deficiencies as possible inducers of these embryopathies. This may encourage comprehensive counselling, particularly of parents of children born with deformities who wish to have more children.


Subject(s)
Cleft Lip/physiopathology , Cleft Palate/physiopathology , Neural Tube Defects/prevention & control , Neural Tube Defects/physiopathology , Tooth Socket/abnormalities , Vitamin B Complex/metabolism , Vitamin B Deficiency/physiopathology , Cleft Lip/prevention & control , Cleft Palate/prevention & control , Humans , Infant, Newborn , Vitamin B Complex/therapeutic use , Vitamin B Deficiency/congenital , Vitamin B Deficiency/prevention & control
4.
Ann Anat ; 189(3): 229-33, 2007.
Article in English | MEDLINE | ID: mdl-17534029

ABSTRACT

Animal experiments are used in embryological and teratological studies of matters relevant to humans. In gravid rats, a decrease in the levels of folic acid and vitamin B12 was observed in maternal blood and in amniotic fluid. At the time of secondary palatal closure (14th day of pregnancy), the folic acid level of the amniotic fluid was 73% lower than that of the maternal blood. A drop in vitamin B12 in conjunction with an increase in amniotic homocysteine levels is seen as a risk factor for malformation of the palate. The understanding of causes of cleft generation could lead to a prophylactic treatment approach.


Subject(s)
Embryonic Development , Folic Acid/metabolism , Homocysteine/metabolism , Palate/embryology , Vitamin B 12/metabolism , Animals , Female , Folic Acid/blood , Homocysteine/blood , Maternal-Fetal Exchange , Pregnancy , Rats , Rats, Inbred Lew , Vitamin B 12/blood
5.
Article in English | MEDLINE | ID: mdl-17052636

ABSTRACT

OBJECTIVE: The aim of this investigation was to test the induction of bone formation and biodegradation of different biomaterials based on calcium phosphate (CaP). Up to now, hydroxyapatite and beta-tricalcium phosphate ceramics have routinely been sintered at temperatures of 1300 degrees C. The new CaP biomaterials tested are fabricated by a sol-gel process at only 700 degrees C. STUDY DESIGN: Critical-size defects (>5 cm(3)) in the mandible of 15 adult Goettingen minipigs were filled with 1 of the 2 new types of CaP biomaterials, or with 1 of 2 well-known old-type ceramics, or with a gelatin sponge (in the control group). Macroscopical, histological, and morphometric examination of the former defect areas were made 8 months postoperatively. RESULTS: Eight months after implantation of the new CaP biomaterials, complete bone formation was observed in the defect area, and at the same time, the foreign material was resorbed almost completely. After implantation of the classical types of ceramics, only incomplete bone formation and a lesser resorption rate of the foreign bodies were noted. The difference in the bone formation rate was significant: more than 93% for the new CaP biomaterials versus less than 58% for the classical types of ceramics (P < 0.01). CONCLUSION: The biological behavior of the new CaP biomaterials was better than that of the old-type sintered ceramic bone-grafting materials. These new CaP matrices are suitable for filling bone defects and are of interest for dentists, including implantologists, craniomaxillofacial and orthopedic surgeons, as well as traumatologists.


Subject(s)
Absorbable Implants , Bone Substitutes , Calcium Phosphates/metabolism , Implants, Experimental , Animals , Biodegradation, Environmental , Bone Regeneration , Calcium Phosphates/chemical synthesis , Mandible/surgery , Porosity , Swine , Swine, Miniature
6.
J Craniomaxillofac Surg ; 33(1): 45-9, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15694149

ABSTRACT

QUESTION: Is it possible to stimulate osteoconduction and osteogenesis to improve bone formation in critical-size defects in order to avoid bone grafting? MATERIAL AND METHODS: Full thickness, critical-sized defects were created in the anterior mandible of 16 adult mini-pigs. The defects were filled with a new bioactive matrix (60% hydroxyapatite and 40% beta-tricalciumphosphate), produced by an innovative low temperature sol-gel-process (120 degrees C). The biomatrix was tested alone and in combination with cultured autologous osteoblasts. In a control group, periosteum was the only bone producing source. Five weeks postoperatively, the animals were sacrificed and the defects analysed macroscopically, histologically and radiographically. RESULTS: The highest rate of new bone formation was in the biomatrix group without osteoblasts (73% of the former defect). The biomatrix was degraded at the same speed as new bone was laid down. In the control group, bone formation of only 59% was observed. Additional transplantation of autologous osteoblasts in combination with the biomatrix did not result in more bone production than in the control group(!). CONCLUSION: This new bioactive calciumphosphate matrix seems to be a promising bone replacement material.


Subject(s)
Bone Regeneration/drug effects , Bone Substitutes/therapeutic use , Calcium Phosphates/toxicity , Hydroxyapatites/toxicity , Mandible/surgery , Animals , Osteoblasts/transplantation , Swine , Swine, Miniature , Transplantation, Autologous
7.
Pathol Res Pract ; 200(1): 33-40, 2004.
Article in English | MEDLINE | ID: mdl-15157048

ABSTRACT

We investigated the effects of prenatal folic acid supplementation on procarbazine (PCZ)-induced intra-uterine growth retardation (IUGR), cleft palates, and microgenia. Three groups of gravid rats were treated with 200 mg/kg body weight (BW) PCZ on day 13.5 of gestation (GD13.5). Two groups of them were additionally supplemented with 1 and 2.5 mg/kg folic acid, respectively, from GD13.5 through GD16.5. On GD19.5, all fetuses were delivered by caesarian sections and sexed subsequently. Numbers of live and dead fetuses as well as resorptions were counted. Data on fetal BW, crown-rump length, tail length, placental weight, and diameter were collected. Fetal heads were histologically scrutinized for the occurrence of cleft palates and microgenia. Folic acid at 2.5 mg/kg diminished PCZ-induced IUGR. In male fetuses, both folic acid doses significantly reduced the incidence of cleft palates and microgenia, while in females, only the high folic acid dose was capable of lowering the occurrence frequency of cleft palates. We conclude that folic acid supplementation at the used doses confers a substantial protection against PCZ-induced IUGR and incidence of cleft palates and microgenia. However, these effects are gender-related and dose-dependent.


Subject(s)
Cleft Palate/prevention & control , Folic Acid/therapeutic use , Hematinics/therapeutic use , Animals , Antineoplastic Agents/toxicity , Cleft Palate/chemically induced , Dietary Supplements , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Fetal Growth Retardation/chemically induced , Fetal Growth Retardation/drug therapy , Male , Pregnancy , Procarbazine/toxicity , Rats , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...